Skip to content
Chandan Healthcare logo

Chandan Healthcare

CHANDAN NSE
₹224.20 unchanged 0.00 (0.00%)
Market Cap
₹548 Cr
P/E
22.15

Chandan Healthcare (CHANDAN) share price was ₹224.20 at the 28 Oct 2026 close; market capitalisation ₹548 Cr; P/E (TTM) 22.15; sector Healthcare Services. The share price fell 31.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 19.1% year on year to ₹80.85 Cr and net profit rose 28.0% year on year to ₹7.92 Cr (compared with Jun 2025). Promoters held 48.42% of Chandan Healthcare in Sep 2026, down 1.19 percentage points from Jun 2026. Its Tapetide Score is 46/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹224.20 −118.10 −34.50% 1Y

Key Fundamentals

SMEHealthcare ServicesHealthcare
Market Cap
₹548 Cr
P/E (TTM)
22.15
EBITDA
₹56.80 Cr
Return on Equity
16.2%
Debt to Equity
0.32
Book Value
₹69.48
EPS (TTM)
₹10.12
52W High
₹358.00
52W Low
₹185.40

Price-based figures as of 29 Oct 2026, 10:27 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

₹1,908.4059.0132,032 Cr12.770.26%20.06%25.67%2,996 Cr545 Cr
₹1,438.2078.8914,813 Cr15.480.14%18.07%19.22%879 Cr187 Cr
₹548.7056.3911,379 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
₹514.7546.468,193 Cr15.982.84%27.79%33.84%894 Cr176 Cr
₹629.60150.266,331 Cr5.670.00%6.88%13.46%1,079 Cr85 Cr
₹318.5546.301,659 Cr6.780.16%12.90%14.70%329 Cr35 Cr
₹497.0016.301,612 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Chandan Healthcare (this company)
₹224.2022.15548 Cr3.230.00%16.20%20.80%294 Cr25 Cr
Median 8 companies₹531.7351.437,262 Cr7.180.21%14.55%17.48%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

46 Average
Overall score

Data confidence 98/100

Category scores

Quality Average 50
Returns, margins, earnings quality 22% weight
Valuation Average 53
Cheap vs sector & own history 24% weight
Growth Strong 70
Sales & profit trajectory 9% weight
Financial Health Weak 42
Solvency, leverage, coverage 9% weight
Momentum Poor 25
Trend strength, vol-adjusted 12% weight
Ownership Poor 32
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.7%

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.41%
  • Debtor days have increased from 82.7 to 114 days.
  • Working capital days have increased from 48.3 days to 95.2 days

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
12
Neutral
7
Bullish
0

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
20.42% lower than 3Y

change over 1 year

Net Income Growth
21.7% lower than 3Y

change over 1 year

Cash Flow Change
688%

change over 1 year

EBITDA Margin Change
8.75%

change over 1 year Operating margin 24.22% · Jun 2026

Quarterly Results

Particulars Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
54.64
62.65
67.9
67.9
65.01
75.58
80.85
Expenses
45.75
52.41
54.03
53.75
53.17
64.1
61.27
Operating Profit
8.89
10.24
13.87
14.15
11.84
11.48
19.58
OPM %
16.27%
16.34%
20.43%
20.84%
18.21%
15.19%
24.22%
Other Income
0.17
2.42
0.87
0.84
-1.46
1.85
1.41
Interest
1.09
1.3
1.37
1.4
1.28
1.78
4.83
Depreciation
1.35
2.7
3.75
2.46
2.4
3.74
4.47
PBT
6.62
8.66
9.62
11.13
6.7
7.81
11.69
Tax %
30.21%
29.56%
35.65%
25.79%
24.93%
36.62%
32.34%
Net Profit
4.2
6.02
6.19
7.8
4.54
4.94
7.92
EPS (₹)
2.1
2.46
2.37
3.19
1.86
2
3.07
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
120
137
177
230
276
289
Expenses
117
128
150
190
224
232
Operating Profit
2
9
26
40
53
57
OPM %
1.9%
7%
15%
18%
19%
20%
Other Income
0
0
1
3
1
3
Interest
2
2
3
5
6
9
Depreciation
2
2
3
7
10
13
PBT
-1
5
21
32
38
37
Tax %
3%
28%
24%
27%
25%
—
Net Profit
-1
3
16
24
29
25
EPS (₹)
-0.56
1.68
8.14
9.07
11.07
10.12
Div. Payout %
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
20
20
20
24
24
Reserves
4
7
21
98
147
Borrowings
17
21
36
48
54
Other Liabilities
41
49
41
40
65
Total Liabilities
82
98
118
211
290
Fixed Assets
29
33
48
76
101
CWIP
0
0
0
4
12
Investments
6
7
3
33
20
Other Assets
46
58
66
98
156
Total Assets
82
98
118
211
290
Figures in ₹ Crores

Cash Flow

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
6
4
1
-3
16
Investing
-11
-6
-15
-62
-40
Financing
3
2
16
67
21
Net Cash Flow
-1
0
2
2
-3
Free Cash Flow
-1
-1
-18
-41
-26
CFO/EBITDA
275
60
23
14
49
Figures in ₹ Crores

Ratios

Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
88
63
59
75
114
Inventory Days
46
71
96
126
112
Days Payable
185
251
102
103
135
Cash Conversion Cycle
-51
-117
53
98
92
Working Capital Days
-11
-21
-1
50
95
ROCE %
—
16%
37%
29%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Chandan Healthcare insights

58 extracted metrics + investor summaries across FY22–FY27.

Shareholding Pattern

DIIs5.06%Promot.48.42%Others7.75%Public38.77%As ofSep 2026

Documents

Frequently Asked Questions about Chandan Healthcare

What does Chandan Healthcare Ltd do?
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
Where is Chandan Healthcare Ltd (CHANDAN) listed?
Chandan Healthcare Ltd trades as CHANDAN on the NSE.
Which sector does Chandan Healthcare Ltd belong to?
Chandan Healthcare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Chandan Healthcare Ltd?
Chandan Healthcare Ltd has a market capitalisation of ₹548.22 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Chandan Healthcare Ltd?
Chandan Healthcare Ltd trades at a PE ratio of 22.15 as of 29 Oct 2026, on earnings per share of ₹10.12, against a book value of ₹69.48 per share.
What is the 52-week high and low of Chandan Healthcare Ltd?
Over the last 52 weeks Chandan Healthcare Ltd has traded between ₹185.4 and ₹358 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Chandan Healthcare Ltd?
Chandan Healthcare Ltd reported a return on equity of 16.20%. Its debt-to-equity ratio is 0.32.

Company Information

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]

Listed 2025-02-17
Face Value ₹ 10
Shares Outstanding 2,44,52,064

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CHANDAN.md for Chandan Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More